Laboratory Corporation of America Holdings
NYSE:LH
Balance Sheet
Balance Sheet Decomposition
Laboratory Corporation of America Holdings
Current Assets | 3.5B |
Cash & Short-Term Investments | 99.3m |
Receivables | 2.2B |
Other Current Assets | 1.2B |
Non-Current Assets | 13.1B |
Long-Term Investments | 17.7m |
PP&E | 2.9B |
Intangibles | 9.6B |
Other Non-Current Assets | 546m |
Current Liabilities | 3.9B |
Accounts Payable | 695.5m |
Accrued Liabilities | 820.6m |
Other Current Liabilities | 2.4B |
Non-Current Liabilities | 4.6B |
Long-Term Debt | 3.1B |
Other Non-Current Liabilities | 1.5B |
Balance Sheet
Laboratory Corporation of America Holdings
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
580
|
716
|
434
|
317
|
427
|
338
|
1 321
|
1 473
|
430
|
537
|
|
Cash Equivalents |
580
|
716
|
434
|
317
|
427
|
338
|
1 321
|
1 473
|
430
|
537
|
|
Total Receivables |
816
|
1 375
|
1 519
|
1 848
|
1 862
|
2 025
|
3 017
|
2 978
|
3 017
|
2 099
|
|
Accounts Receivables |
816
|
1 375
|
1 519
|
1 848
|
1 862
|
2 025
|
3 017
|
2 978
|
3 017
|
2 099
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
140
|
191
|
205
|
227
|
237
|
245
|
423
|
401
|
471
|
475
|
|
Other Current Assets |
158
|
339
|
321
|
343
|
309
|
374
|
365
|
478
|
707
|
655
|
|
Total Current Assets |
1 693
|
2 621
|
2 479
|
2 734
|
2 835
|
2 981
|
5 125
|
5 331
|
4 625
|
3 765
|
|
PP&E Net |
787
|
1 747
|
1 719
|
1 707
|
1 785
|
2 724
|
2 809
|
2 897
|
3 031
|
2 981
|
|
PP&E Gross |
787
|
1 747
|
1 719
|
1 707
|
1 785
|
2 724
|
2 809
|
2 897
|
3 031
|
2 981
|
|
Accumulated Depreciation |
1 027
|
1 124
|
1 392
|
1 559
|
1 773
|
1 929
|
2 203
|
2 413
|
2 723
|
2 905
|
|
Intangible Assets |
1 476
|
3 324
|
3 401
|
4 166
|
3 911
|
4 035
|
3 961
|
3 736
|
3 947
|
3 342
|
|
Goodwill |
3 099
|
6 202
|
6 424
|
7 401
|
7 360
|
7 865
|
7 752
|
7 959
|
8 121
|
6 143
|
|
Long-Term Investments |
93
|
58
|
58
|
58
|
61
|
85
|
74
|
61
|
66
|
27
|
|
Other Long-Term Assets |
155
|
152
|
167
|
607
|
233
|
357
|
351
|
403
|
365
|
467
|
|
Other Assets |
3 099
|
6 202
|
6 424
|
7 401
|
7 360
|
7 865
|
7 752
|
7 959
|
8 121
|
6 143
|
|
Total Assets |
7 302
N/A
|
14 105
+93%
|
14 247
+1%
|
16 673
+17%
|
16 185
-3%
|
18 046
+11%
|
20 072
+11%
|
20 385
+2%
|
20 155
-1%
|
16 725
-17%
|
|
Liabilities | |||||||||||
Accounts Payable |
282
|
497
|
508
|
574
|
635
|
632
|
639
|
621
|
935
|
828
|
|
Accrued Liabilities |
255
|
469
|
484
|
677
|
705
|
992
|
1 175
|
1 352
|
1 108
|
842
|
|
Short-Term Debt |
0
|
95
|
42
|
9
|
8
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
347
|
329
|
507
|
409
|
10
|
424
|
383
|
12
|
307
|
1 006
|
|
Other Current Liabilities |
92
|
311
|
285
|
517
|
522
|
608
|
881
|
798
|
728
|
549
|
|
Total Current Liabilities |
976
|
1 701
|
1 828
|
2 186
|
1 879
|
2 656
|
3 079
|
2 783
|
3 079
|
3 225
|
|
Long-Term Debt |
2 683
|
5 940
|
5 300
|
6 345
|
6 042
|
5 881
|
5 503
|
5 501
|
5 122
|
4 133
|
|
Deferred Income Tax |
530
|
1 181
|
1 206
|
876
|
940
|
943
|
905
|
763
|
736
|
418
|
|
Minority Interest |
18
|
15
|
15
|
21
|
19
|
20
|
21
|
21
|
19
|
16
|
|
Other Liabilities |
274
|
323
|
392
|
442
|
334
|
980
|
1 204
|
1 045
|
1 103
|
1 058
|
|
Total Liabilities |
4 481
N/A
|
9 160
+104%
|
8 741
-5%
|
9 869
+13%
|
9 214
-7%
|
10 479
+14%
|
10 712
+2%
|
10 112
-6%
|
10 059
-1%
|
8 850
-12%
|
|
Equity | |||||||||||
Common Stock |
10
|
12
|
12
|
12
|
12
|
9
|
9
|
9
|
8
|
8
|
|
Retained Earnings |
3 786
|
4 224
|
4 956
|
6 196
|
7 080
|
7 904
|
9 402
|
10 457
|
10 582
|
7 888
|
|
Additional Paid In Capital |
0
|
1 975
|
2 132
|
1 990
|
1 451
|
27
|
110
|
0
|
0
|
38
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Treasury Stock |
966
|
978
|
1 013
|
1 060
|
1 108
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
11
|
287
|
581
|
334
|
463
|
372
|
162
|
192
|
493
|
59
|
|
Total Equity |
2 821
N/A
|
4 945
+75%
|
5 506
+11%
|
6 804
+24%
|
6 971
+2%
|
7 567
+9%
|
9 360
+24%
|
10 273
+10%
|
10 097
-2%
|
7 875
-22%
|
|
Total Liabilities & Equity |
7 302
N/A
|
14 105
+93%
|
14 247
+1%
|
16 673
+17%
|
16 185
-3%
|
18 046
+11%
|
20 072
+11%
|
20 385
+2%
|
20 155
-1%
|
16 725
-17%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
85
|
101
|
103
|
102
|
99
|
97
|
98
|
93
|
88
|
84
|